2021 Investor Day

Long-term financial goals Meet or exceed annual market growth ranges Drive operating margin of 30%+ Increase recurring revenue Reinforce geographic diversity Market growth expectations: Devices Masks & Accessories Mid single-digit High single-digit SaaS Mid to high single-digit Driven by continued positive operating leverage and disciplined supply chain management Driven by improved patient adherence due to SaaS solutions and revenue growth from mask and device resupply Building a best-in-class global workforce and footprint ResMed plans to meet or beat market growth across all segments © 2021 ResMed | 2021 Investor Day – Sept 8, 2021 87

View entire presentation